0.20 USD
▼-0.01-2.46%
盘后 0.63 0.00%
2026-09-16
市值
$2.84M
市盈率
—
EPS
-239.19
股息率
—
52 周区间
0.19 – 2,360.00
成交量
3.96M
Beta
1.45
目标价
—
52W 低 0.1952W 高 2,360.00
价格走势
公司简介
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also ...